CTL effector mechanisms: diagnostic applications
Asher D. Schachter(Visterra (United States)), Terry B. Strom, Vuddidhej Ophascharoensuk(Beth Israel Deaconess Medical Center), Xin Xiao Zheng(Beth Israel Deaconess Medical Center), J. Strehlau(Beth Israel Deaconess Medical Center), Lauro Vasconcellos(Beth Israel Deaconess Medical Center)
Cited by 3
Related Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential
|The Journal of Experimental Medicine|2003|897
Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination
|Science|2000|885
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible
|Nature Genetics|2006|567
CD39 and control of cellular immune responses
|Purinergic Signalling|2007|289